Survival among US women with invasive epithelial ovarian cancer

被引:132
作者
McGuire, V [1 ]
Jesser, CA [1 ]
Whittemore, AS [1 ]
机构
[1] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA
关键词
ovarian cancer; survival; race/ethnicity;
D O I
10.1006/gyno.2001.6536
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. Invasive epithelial ovarian cancer is a highly fatal disease, diagnosed at advanced stages when survival is poor. Relatively little is known about the variation in survival across U.S. women of different race/ethnicities. To investigate this issue, we evaluated pathological characteristics and death rates due to invasive epithelial ovarian cancer in a population-based sample of patients from six racial/ethnic groups. Methods. The analysis included 38,012 women diagnosed with primary invasive epithelial ovarian cancer between 1973 and 1997 in the Surveillance, Epidemiology and End Results Program of the National Cancer Institute. Results. Filipina patients were younger at diagnosis, more likely to have localized disease, and had more mucinous cancers than whites. African-Americans were more likely than whites to be diagnosed at older ages, with distant disease and with undifferentiated/unclassified cancers. After adjusting for age at diagnosis, stage of disease at diagnosis, and cancer histology, we found that, compared to whites, death rates were significantly elevated among African-Americans and significantly reduced among Hispanics and Filipina. We also found that death rates declined significantly with time since diagnosis among women with advanced disease. Conclusion. The declining death rates in women with advanced disease suggest the presence of considerable prognostic heterogeneity among these women, which could reflect differences in quality of care. This issue, as well as the survival disadvantage for African-American women and survival advantages for Hispanic and Filipina women, needs investigation. (C) 2002 Elsevier Science (USA).
引用
收藏
页码:399 / 403
页数:5
相关论文
共 24 条
[11]   FIGO STAGE, HISTOLOGY, HISTOLOGIC GRADE, AGE AND RACE AS PROGNOSTIC FACTORS IN DETERMINING SURVIVAL FOR CANCERS OF THE FEMALE GYNECOLOGICAL SYSTEM - AN ANALYSIS OF 1973-87 SEER CASES OF CANCERS OF THE ENDOMETRIUM, CERVIX, OVARY, VULVA, AND VAGINA [J].
KOSARY, CL .
SEMINARS IN SURGICAL ONCOLOGY, 1994, 10 (01) :31-46
[12]   THE PROGNOSTIC-SIGNIFICANCE OF RESIDUAL DISEASE, FIGO SUBSTAGE, TUMOR HISTOLOGY, AND GRADE IN PATIENTS WITH FIGO STAGE-III OVARIAN-CANCER [J].
MAKAR, AP ;
BAEKELANDT, M ;
TROPE, CG ;
KRISTENSEN, GB .
GYNECOLOGIC ONCOLOGY, 1995, 56 (02) :175-180
[13]  
Meden H, 1997, ANTICANCER RES, V17, P757
[14]   Trends in United States ovarian cancer mortality, 1979-1995 [J].
Oriel, KA ;
Hartenbach, EM ;
Remington, PL .
OBSTETRICS AND GYNECOLOGY, 1999, 93 (01) :30-33
[15]  
Parham G, 1997, CANCER, V80, P816
[16]  
Reles A, 2001, CLIN CANCER RES, V7, P2984
[17]  
RIES LAG, 1993, CANCER-AM CANCER SOC, V71, P524
[18]  
RIES LAG, 2001, SEER CANC STAT REV
[19]  
*SAS I INC, 2000, SAS SYST MICR WIND R
[20]  
Schiff M, 1996, CANCER EPIDEM BIOMAR, V5, P323